The New Eugenics
By Jesse Reynolds,
Z Magazine
| 10. 31. 2002
As this article is being written, delegates from nearly every country are meeting at the United Nations to take the next steps towards an international convention banning human reproductive cloning. Human cloning is the latest, and loudest, in a series of new technologies of human reproductive and genetic manipulation that have – and will – elicit controversy and division in civil society. Additionally, enormous payments to egg “donors” with specific characteristics have been in college newspapers for several years (see “Assisted Reproductive Technologies,” July/August 2002, Z Magazine). Recently, the use of pre-implantation genetic diagnosis, in which embryos are screened for certain genetic characteristics before implantation via in vitro fertilization (IVF), for gender selection or non-disease traits has garnered attention. Soon, we can expect to see public debate over inheritable human genetic engineering, the technology with the greatest potential for social and biological impacts.
Human reproductive cloning is neither far-off science fiction nor banned taboo. The technology is imminent, and several rogue scientists are working to create cloned children. Although more than thirty countries have already passed laws prohibiting reproductive cloning...
Related Articles
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...
By Emily Glazer, Katherine Long, Amy Dockser Marcus, The Wall Street Journal | 11.08.2025
For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.
Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...
By Heidi Ledford, Nature | 10.31.2025
Late last year, dozens of researchers spanning thousands of miles banded together in a race to save one baby boy’s life. The result was a world first: a cutting-edge gene-editing therapy fashioned for a single person, and produced in...
By Lauran Neergaard, AP News | 11.03.2025
WASHINGTON (AP) — The first clinical trial is getting underway to see if transplanting pig kidneys into people might really save lives.
United Therapeutics, a producer of gene-edited pig kidneys, announced Monday that the study’s initial transplant was performed successfully...